Cpd Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -26.79%
- Profit Growth -35.84%
- Ebitda -202.93%
- Net Worth -214.75%
- Total Assets -30.33%
About Cpd Pharma
Cpd Pharma Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 June 2019 (Five years and eight months 4 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sivakumar Narasimhan, Srinivasan Karthikeyan, and Katragadda Varaprasad serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909TN2019PTC130073
- Company No.
130073
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jun 2019
- Date of AGM
05 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Cpd Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sivakumar Narasimhan  | Additional Director | 19-Jan-2024 | Current |
| Srinivasan Karthikeyan | Director | 23-Feb-2021 | Current |
| Katragadda Varaprasad | Director | 23-Feb-2021 | Current |
Financial Performance of Cpd Pharma.
Cpd Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 26.79% decrease. The company also saw a substantial fall in profitability, with a 35.84% decrease in profit. The company's net worth observed a substantial decline by a decrease of 214.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cpd Pharma?
In 2023, Cpd Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Avis Healthcare Private LimitedSivakumar Narasimhan is a mutual person
New Rrpd Private LimitedSivakumar Narasimhan is a mutual person
- New Siva Agencies Private Limited
Sivakumar Narasimhan is a mutual person
- Suswadeep Oils Private Limited
Katragadda Varaprasad is a mutual person
- Rada Medisolutions Private Limited
Katragadda Varaprasad is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cpd Pharma?
Cpd Pharma has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cpd Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cpd Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
